moneyheap
BDMD · Analysis updated Nov 6, 2026, 2:39 AM ET
Why is Baird Medical Investment Holdings Ltd Ordinary Share (BDMD) stock moving?
Baird Medical (BDMD) has experienced extreme downward price pressure and hyper-volatility over the past 30 days, plunging from around $0.60 to a low of $0.0725 before a speculative volume spike drove a close at $0.1575 on November 5. The steep sell-off triggered an official Nasdaq minimum bid price deficiency notice on November 2, granting the company 180 days (until May 3, 2027) to regain compliance above $1.00. While the company announced commercial expansion via China Resources Pharmaceutical and regulatory filings for its partnered IRE ablation system, underlying fundamentals show severe distress, including deeply negative operating margins, continuing cash burn, and significant delisting/dilution risks.
News behind the analysis
- Baird Medical (BDMD) Stock Sinks 33% in After-Hours TradingBDMD shares experienced severe volatility, dropping 33% in after-hours trading despite announcing FDA 510(k) and EU CE submissions for an IRE system.
- Baird Medical and Alpmed Announce FDA 510(k) and EU CE Submissions for Irreversible Electroporation (IRE) SystemStrategic partner Alpmed submitted regulatory filings in the U.S. and Europe for an IRE system, with Baird holding worldwide commercial rights.
- Baird Medical Announces Nasdaq Minimum Bid Price Deficiency with 180-Day Cure PeriodBaird Medical received a formal deficiency notice from Nasdaq after closing below $1.00 for 30 consecutive business days, granting until May 3, 2027 to regain compliance.
- Baird Medical Issues Statement Regarding Recent Share Price VolatilityThe company issued a formal statement clarifying that no undisclosed operational setbacks or material developments explain the severe drop in share price.
- Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution AgreementBaird Medical signed an exclusive distribution agreement across 19 Chinese provincial markets with an initial RMB 6 million (~$900,000) purchase order.